ArticleCureus2026
Toxic Epidermal Necrolysis in Pregnancy: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, severe mucocutaneous adverse drug reactions associated with significant morbidity and mortality. SJS or TEN during pregnancy is rare and presents with unique diagnostic and management challenges, with potential risks to both the mother and fetus. We report a case of a 25-year-old primigravida at 29 weeks of gestation who presented with widespread cutaneous eruptions following ingestion of an over-the-counter herbal medication for headache. Clinical examination revealed extensive erythematous macules involving the face, trunk, limbs and genital region. Based on characteristic clinical features, extent of epidermal detachment, and temporal association with drug exposure, a diagnosis of TEN was established. The patient went into spontaneous preterm labor and delivered a male neonate vaginally. Multidisciplinary management with systemic corticosteroids and supportive care resulted in gradual clinical improvement and complete re-epithelialization. Both the mother and neonate had favorable outcomes. This case highlights the importance of early clinical recognition of TEN in pregnancy and emphasizes that even herbal and alternative medications may precipitate severe cutaneous adverse reactions. Prompt withdrawal of the offending agent, multidisciplinary supportive care, and individualized obstetric management are essential to optimize maternal and fetal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.